nematoden

Since the discovery of microRNAs (miRNAs) some twenty years ago by Victor Ambros, David Baulcombe and Gary Ruvkun, these three scientists worked to uncover the mystery of miRNA, the small segments of nucleotides that silence genes. While studying the development of the nematode worm, Ambros and Ruvkun discovered miRNA in animals, while Baulcombe discovered it in plants. Since their discovery, it took more than two decade to fully appreciate the value of miRNA in human health and diseases. Emerging evidence suggest that the activation of oncogenes and/or the inactivation of tumor suppressor genes contribute to the development and progression of tumors. The regulation of genes is by far controlled by many transcription factors which are often deregulated during the development and progression of cancer. In addition, emerging evidence clearly suggests that the deregulation of miRNAs or small non-coding RNAs could also regulate the expression of genes and likewise, miRNA genes are also regulated by transcription factors. The most attractive feature of miRNAs is that one miRNA can regulate many target genes (mRNAs) and thus miRNA targeted therapy is highly promising because multiple genes could be regulated by targeting a single miRNA, which becomes very important for the killing of highly heterogeneous populations of cancer cells within a tumor mass. Therefore, miRNA targeted therapy is an attractive attribute of miRNA research, which is covered through eighteen chapters complied in this book “MicroRNA targeted Cancer therapy” and it is hoped that the field of miRNA research will be appreciated through critical reading of these chapters on the cutting-edge research on miRNAs.

Frontmatter -- Preface -- Contents -- Part I. Biological Effects and Biological Functions of Lectins -- Histophathological Changes Induced in Mice by the Plant Toxin Ricin and its Highly Purified Subunits A-Chain and B-Chain -- Suppression of Experimental Allergic Encephalomyelitis in Guinea Pigs and Rats by Concanavalin A -- Lectins, Allergens and Mucus -- Effect of Viscum Lectin on Histamine Release from Human Leukocytes -- Analysis of the Recycling Behaviour of Galactose-Specific Lectins on Rat Liver Cells -- Interaction of Soybean Agglutinin with Human Peripheral Blood Lymphocyte Subpopulations: Evidence for the Existence of a Lectin-Like Substance on the Lymphocyte Surface -- A Recognition Mechanism in the Adhesion of Nematodes to Nematode-Trapping Fungi -- The Lectin-Producing Cells in the Sponge Tissue -- The Non-Random Distribution of Lectin in the Azolla caroliniana-Anabaena azollae Symbiosis -- Distribution, Specificity and in vivo Significance of Phytolectins -- Occurrence of Lectin During the Life Cycle of Lathyrus Species -- Part II. Cell Receptors and Cell Reactions -- Monosaccharides and Tamm-Horsefal1 Glycopeptide Inhibit Allogeneic Antigen-Induced Lymphocyte Blàstogenesis in One-Way Mixed Lymphocyte Reaction -- Murine 3T3 Cell Deformability and Concanavalin A Agglutination -- Correlation with a Physical Model System -- Lectin Binding to and Lectin Induced Agglutination of Haemopoietic Cells -- Lectin Binding by Malaria Infected Erythrocytes -- A Tumor Specific WGA-Receptor on a Chemically Induced Carcinoma -- Distribution of Lectin Receptors in Neonatal and Embryonic Mouse Tissue -- Interaction of Peroxidase-Coupled Helix pomatia Lectin with Rat Hepatoma Cells -- Use of Lectins for the Characterization of the Insulin Receptor Glycosidic Moiety in Rat Adipocytes and Hepatocytes -- Ricin 120 as a Selective Marker in the Nervous System -- The Role of the Cell Coat in Palatal Shelves Adhesion. The Action of Neuraminidase and Limulus polyphemus Lectin on Shelves Cultivated in vitro -- Mobility of Con A Receptors at the Surface of Palatal Shelves before Closure of the Secondary Palate -- Increased Alpha-Galactosidase Activity in Normal and Fabry Fibroblasts Treated with Con A and Purified Enzyme -- Lectin-Induced Surface Changes in Lymphocytes of Gnotobiotic Pigs -- Mitogenic Lectins and Alpha-Fetoprotein as Modulators of Lymphocyte Surface Enzyme Activities -- Part III. Macromolecules and Lectins -- Specific Interaction of R-Type Lipopolysaccharides with Lectins Versus their Non-Specific Reactivity with Basic and Hydrophobic Proteins -- Lectin Receptors in Proteogalactans from the Albumin Gland of Achatina fulica -- Affinity of Leucoagglutinin (L-PHA), Compared with Dolichos biflorus Lectin and Con A, for Human Tamm- Horsefall Glycopeptide -- Interaction of Haptoglobin with Lectin -- Interaction of Polyclonal and Monoclonal Human Immunoglobulins G with Various Lectins (Concanavalin A, Lentil and Pea Lectins) -- Changes in the Relative Amount of Individual Microheterogeneous Eorms of Serum Alpha-l-Antichymotrypsin in Disease -- Study of the ConA Binding of Human Alpha-1 Acid Glycoprotein during the Acute Inflammatory Process. Evidence for Alpha-1 Acid Glycoprotein Populations of Different pi Values after ConA Affinity Chromatography in Normal and Inflammatory Sera -- Crossed Affinity Immunoelectrophoresis of Factor VIII- Related Antigen in van Willebrand's Disease -- Comparability of Carbohydrate Heterogeneity Patterns of Human Alpha-Fetoprotein in Different Biological Fluids -- Demonstration and Quantification of Microheterogeneity Forms of Human Alpha-Fetoprotein by Lectin Affinity Electrophoresis -- Estimation of ConA-Binding and Non-Binding Forms of Human Alpha-Fetoprotein (AFP) by Rocket Line Affino Immuno Electrophoresis -- Crossed Charge-Shift Affino-Immunoelectrophoresis of Human and Murine Alpha-Fetoprotein (AFP) -- Heterogeneity of Human Ferritins Studied by Crossed Lectin-Affinity-Radioimmunoelectrophore

Blumenmischung "Nützlingsparadies" Dekorative Mischung, die speziell zur Unterstützung für integrierten Pflanzenschutz zusammengestellt ist. In Rabatten um Gemüseflächen angelegt, locken die Pflanzen dieser Mischung einerseits Nützlinge an und können andererseits auch zur Bodenverbesserung beitragen. Zum einen durch Arten, die die Entwicklung von Nematoden hemmen (Samtblume), zum anderen durch Arten die einen raschen Abbau von Pflanzenresten fördern (Ringelblume). Diese Mischung ist ausschließlich für die Aussaat im Frühjahr geeignet! Nützlingsparadies besteht aus 9 einjährigen und 11 mehrjährigen Arten wie z.B.: Schafgarbe, Steinkresse, Kamille, Basilikum, Ringelblume, Koriander, Natterkopf, Samtblume, Balsamkraut usw. Aussaatmenge: 2-3 g/m² Aussaatzeit: April bis Juni Wuchshöhe: 30-60 cm Flächenleistung: 25 m² oder 250 m² Blüte: Juli bis September Nettogewicht: 50 g oder 500 g Hinweis: Eine Blumenwiese sollte nicht öfter als zwei bis drei Mal pro Jahr gemäht werden. Zumindest einmal im Spätherbst sollte die Wiese gemäht werden, um im Folgejahr wieder für eine prächtige Wiese zu sorgen. Wir empfehlen die Wiese maximal auf 10 bis 15 cm zu kürzen (z.B. mit einer Motorsense). Nach dem Mähen der Blumenwiese soll das Schnittgut direkt auf der Fläche abtrocknen und erst danach eingeholt werden. So können Samenkapseln beim Trocknen noch aufplatzen und die ausgereiften Samen auf die Erde fallen. Das ist für einen natürlichen Kreislauf wichtig. Die erfolgreiche Aussaat: Die Bodentemperatur sollte nicht zu kalt sein! (mehr als 8°C auch in der Nacht) Eventuell vorhandenen Bewuchs, wie Gräser, Rasen, etc. vollständig entfernen und Boden auflockern Bei nährstoffreichen Böden, den Boden durch Beimischung von Sand abmagern. Saatgut zur leichteren Ausbringung mit 3-facher Menge Sand vermischen Saatgut nur leicht in den Boden einarbeiten (z.B. mit dem Mini-Spiker) Vor Vogelfraß schützen Bis zur Keimung feucht halten (mindestens 4 Wochen) Keinesfalls düngen! Geduld bewahren! Die Keimzeit kann sortenabhängig bis zu 6 Wochen betragen. Bis zu ersten Blüten können im Ansaatjahr bis zu 8 Wochen verstreichen. Das Blumenwiesensaatgut, welches ihr hier im Rasendoktor-Shop erhaltet, zeichnet sich durch eine große Vielfalt an qualitativ hochwertigen Blumensorten, sowie hoher Reinheit und hoher Keimrate aus. Bei Saatgut für Blumenwiesen existieren keine gesetzlichen Qualitäts-Bestimmungen. Daraus ergeben sich sehr große Qualitätsunterschiede im Angebot, etwa im Vergleich zu herkömmlichen Blumenwiesensaatgut vom Discounter.

Since the discovery of microRNAs (miRNAs) some twenty years ago by Victor Ambros, David Baulcombe and Gary Ruvkun, these three scientists worked to uncover the mystery of miRNA, the small segments of nucleotides that silence genes. While studying the development of the nematode worm, Ambros and Ruvkun discovered miRNA in animals, while Baulcombe discovered it in plants. Since their discovery, it took more than two decade to fully appreciate the value of miRNA in human health and diseases. Emerging evidence suggest that the activation of oncogenes and/or the inactivation of tumor suppressor genes contribute to the development and progression of tumors. The regulation of genes is by far controlled by many transcription factors which are often deregulated during the development and progression of cancer. In addition, emerging evidence clearly suggests that the deregulation of miRNAs or small non-coding RNAs could also regulate the expression of genes and likewise, miRNA genes are also regulated by transcription factors. The most attractive feature of miRNAs is that one miRNA can regulate many target genes (mRNAs) and thus miRNA targeted therapy is highly promising because multiple genes could be regulated by targeting a single miRNA, which becomes very important for the killing of highly heterogeneous populations of cancer cells within a tumor mass. Therefore, miRNA targeted therapy is an attractive attribute of miRNA research, which is covered through eighteen chapters complied in this book “MicroRNA targeted Cancer therapy” and it is hoped that the field of miRNA research will be appreciated through critical reading of these chapters on the cutting-edge research on miRNAs.

Since the discovery of microRNAs (miRNAs) some twenty years ago by Victor Ambros, David Baulcombe and Gary Ruvkun, these three scientists worked to uncover the mystery of miRNA, the small segments of nucleotides that silence genes. While studying the development of the nematode worm, Ambros and Ruvkun discovered miRNA in animals, while Baulcombe discovered it in plants. Since their discovery, it took more than two decade to fully appreciate the value of miRNA in human health and diseases. Emerging evidence suggest that the activation of oncogenes and/or the inactivation of tumor suppressor genes contribute to the development and progression of tumors. The regulation of genes is by far controlled by many transcription factors which are often deregulated during the development and progression of cancer. In addition, emerging evidence clearly suggests that the deregulation of miRNAs or small non-coding RNAs could also regulate the expression of genes and likewise, miRNA genes are also regulated by transcription factors. The most attractive feature of miRNAs is that one miRNA can regulate many target genes (mRNAs) and thus miRNA targeted therapy is highly promising because multiple genes could be regulated by targeting a single miRNA, which becomes very important for the killing of highly heterogeneous populations of cancer cells within a tumor mass. Therefore, miRNA targeted therapy is an attractive attribute of miRNA research, which is covered through eighteen chapters complied in this book “MicroRNA targeted Cancer therapy” and it is hoped that the field of miRNA research will be appreciated through critical reading of these chapters on the cutting-edge research on miRNAs.